Jiang Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiang Ni has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Anam Razzaq
College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, PR China
4 shared publications- Haroon Iqbal
State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China
4 shared publications Naveed Ullah Khan
Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar 25000, Pakistan
3 shared publications- Yang Ding
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China
3 shared publications - Naveed Ullah Khan
College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310012, China
2 shared publications Nayyer Islam
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, GC University, Faisalabad, Pakistan
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1959910
Astrocytic ATP13A2 modulates neuroinflammatory responses via mitochondrial fission in Parkinson’s disease
Background: Parkinson’s disease (PD) is a global health problem that urgently requires deeper mechanistic insights. Mutations in the ATPase cation transporting 13A2 ( ATP13A2 ) gene are linked to autosomal recessive PD, yet the pathological roles of this gene remain incompletely defined. Previous studies on ATP13A2 have focused mainly on its lysosomal functions in neurons, whereas its role in astrocytes has been largely overlooked. Here, we investigated how ATP13A2 affects astrocytic mitochondrial function and contributes to PD pathology. Results: Using PD mice and Atp13a2 knockout mice, we found that loss of Atp13a2 disrupts mitochondrial morphology and dynamics in the substantia nigra, with astrocytes showing both excessive fission and activation. We further found that Atp13a2 deficiency caused excessive mitochondrial fission, elevated reactive oxygen species (ROS) levels, and promoted extracellular double-stranded DNA release. ELISA measurements revealed significantly increased secretion of IL-1β, IL-6, and TNF-α, indicating increased release of pro-inflammatory cytokines. Importantly, both pharmacological inhibition of fission via Mdivi-1 and Atp13a2 overexpression restored mitochondrial dynamics homeostasis, suppressed oxidative stress, and reduced cytokine secretion. Collectively, these findings demonstrate that ATP13A2 preserves the mitochondrial fission-fusion balance in astrocytes; its loss breaks this balance, thereby triggering neuroinflammation. Conclusion: By uncovering previously unrecognized roles of ATP13A2 in regulating mitochondrial fission and subsequent neuroinflammation, this study provides new insights into PD pathogenesis and identifies potential molecular targets for therapy. These findings open fresh avenues for developing more effective strategies to modify PD progression.
- 14 October 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1959910
Open AccessAstrocytic ATP13A2 modulates neuroinflammatory responses via mitochondrial fission in Parkinson’s disease
Background: Parkinson’s disease (PD) is a global health problem that urgently requires deeper mechanistic insights. Mutations in the ATPase cation transporting 13A2 ( ATP13A2 ) gene are linked to autosomal recessive PD, yet the pathological roles of this gene remain incompletely defined. Previous studies on ATP13A2 have focused mainly on its lysosomal functions in neurons, whereas its role in astrocytes has been largely overlooked. Here, we investigated how ATP13A2 affects astrocytic mitochondrial function and contributes to PD pathology. Results: Using PD mice and Atp13a2 knockout mice, we found that loss of Atp13a2 disrupts mitochondrial morphology and dynamics in the substantia nigra, with astrocytes showing both excessive fission and activation. We further found that Atp13a2 deficiency caused excessive mitochondrial fission, elevated reactive oxygen species (ROS) levels, and promoted extracellular double-stranded DNA release. ELISA measurements revealed significantly increased secretion of IL-1β, IL-6, and TNF-α, indicating increased release of pro-inflammatory cytokines. Importantly, both pharmacological inhibition of fission via Mdivi-1 and Atp13a2 overexpression restored mitochondrial dynamics homeostasis, suppressed oxidative stress, and reduced cytokine secretion. Collectively, these findings demonstrate that ATP13A2 preserves the mitochondrial fission-fusion balance in astrocytes; its loss breaks this balance, thereby triggering neuroinflammation. Conclusion: By uncovering previously unrecognized roles of ATP13A2 in regulating mitochondrial fission and subsequent neuroinflammation, this study provides new insights into PD pathogenesis and identifies potential molecular targets for therapy. These findings open fresh avenues for developing more effective strategies to modify PD progression.
- 26 September 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 383 (Pt 1) , 154642
A programmed oxidized alginate/chitosan sandwich-layered dressing for sequential regulation of diabetic wound healing
- 26 September 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 383 (Pt 1) , 154642
A programmed oxidized alginate/chitosan sandwich-layered dressing for sequential regulation of diabetic wound healing
- 28 March 2026
- Published by Elsevier in Biomaterials
- Vol. 333, 124163
Dysfunctional microglia-targeted nanoscavenger synergistically accelerates Aβ clearance and inhibits inflammatory cascade
- 28 March 2026
- Published by Elsevier in Biomaterials
- Vol. 333, 124163
Dysfunctional microglia-targeted nanoscavenger synergistically accelerates Aβ clearance and inhibits inflammatory cascade
- Open Access
- 4 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 31, 101633
Tailored virus-mimicking nanoparticles mediate high transfection of pTRAIL for bystander effects in oncotherapy
- 4 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 31, 101633
Open AccessTailored virus-mimicking nanoparticles mediate high transfection of pTRAIL for bystander effects in oncotherapy
- 6 March 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 263, 130694
Albumin-coated green-synthesized zinc oxide nanoflowers inhibit skin melanoma cells growth via intra-cellular oxidative stress
- 6 March 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 263, 130694
Albumin-coated green-synthesized zinc oxide nanoflowers inhibit skin melanoma cells growth via intra-cellular oxidative stress
- Open Access
- 1 December 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (12) , 101839
Self-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement; in vitro and in vivo assessment
Itraconazole (ITZ) is a renowned antifungal medication, however its therapeutic efficacy is limited by low solubility and oral bioavailability. The current research work attempted to augment the oral bioavailability of ITZ by incorporating into self-emulsifying micelles (SEMCs). To fabricate the SEMCs, various preparation techniques including physical mixture, melt-emulsification, solvent evaporation and kneading, were opted by using different weight ratio of drug and solubilizers i.e. Gelucire-50/13 or Gelucire-44/14 and characterized both in vitro and in vivo. The prepared SEMCs were found to be in the size range from 63.4 ± 5.2 to 284.2 ± 19.5 nm with surface charges ranging from −16 ± 1.2 to −27 ± 2.0 mV. The drug solubility was improved to a reasonable extent with all investigated formulations, however, SEMCs in group 6 prepared by kneading method (KMG6) using Gelucire-44/14: drug (10:1 presented 87.6 folds’ increase (964.93 ± 2 μg/mL) compared to solubility of crystalline ITZ (11 ± 2 μg/mL) through kneading method. In addition, KMG6 SEMCs shows the fast drug release compared to other SEMCs. Further, KMG6 SEMCs also exhibited 5.12-fold higher relative intestinal serosal fluid absorption compared to crystalline ITZ. The pharmacokinetic parameters such Cmax, AUC and Tmax of KMG6 SEMCs significantly improved compared to crystalline ITZ. In conclusion, the manipulation of ITZ solubility, dissolution rate and absorption using SEMCs is a promising strategy for bioavailability enhancement.
- 1 December 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (12) , 101839
Open AccessSelf-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement; in vitro and in vivo assessment
Itraconazole (ITZ) is a renowned antifungal medication, however its therapeutic efficacy is limited by low solubility and oral bioavailability. The current research work attempted to augment the oral bioavailability of ITZ by incorporating into self-emulsifying micelles (SEMCs). To fabricate the SEMCs, various preparation techniques including physical mixture, melt-emulsification, solvent evaporation and kneading, were opted by using different weight ratio of drug and solubilizers i.e. Gelucire-50/13 or Gelucire-44/14 and characterized both in vitro and in vivo. The prepared SEMCs were found to be in the size range from 63.4 ± 5.2 to 284.2 ± 19.5 nm with surface charges ranging from −16 ± 1.2 to −27 ± 2.0 mV. The drug solubility was improved to a reasonable extent with all investigated formulations, however, SEMCs in group 6 prepared by kneading method (KMG6) using Gelucire-44/14: drug (10:1 presented 87.6 folds’ increase (964.93 ± 2 μg/mL) compared to solubility of crystalline ITZ (11 ± 2 μg/mL) through kneading method. In addition, KMG6 SEMCs shows the fast drug release compared to other SEMCs. Further, KMG6 SEMCs also exhibited 5.12-fold higher relative intestinal serosal fluid absorption compared to crystalline ITZ. The pharmacokinetic parameters such Cmax, AUC and Tmax of KMG6 SEMCs significantly improved compared to crystalline ITZ. In conclusion, the manipulation of ITZ solubility, dissolution rate and absorption using SEMCs is a promising strategy for bioavailability enhancement.
- 25 August 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 230, 113526
Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics
- 25 August 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 230, 113526
Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics
- Open Access
- 3 July 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (7) , 798
Eco-Friendly Sustainable Nanocarriers to Treat Oxidative Stresses and Skin Aging-Related Ailments, Valorization of a By-Product
The peel from Citrus-sinensis L. is a medicinally significant food waste, and its extract (O-Ext) could be significant against oxidative stresses and skin aging, However, the penetration barriers, instability in formulation, undefined toxicities, and enzymatic activities make the O-Ext difficult to formulate and commercialize. The goal of this study was to evaluate O-Ext against oxidative stress, prepare O-Ext-loaded nano-lipid carriers (O-NLCs), and load them into topical O/W-emulsion (O-NLC-E) to improve O-Ext permeation and its in vivo antiaging effects. TPC, TFC, DPPH activity, and mineral/metal contents of O-Ext were determined via atomic-absorption spectroscopy. For bioactive compounds profiling, GC-MS analysis was carried out. O-NLCs were prepared and tested for physicochemical attributes, while HaCaT and fibroblast cells were used to study permeation and cytotoxicity. The kinetic characteristics of ex vivo permeation through rat skin were established, following the Higuchi model. Following written consent, safety investigations were conducted on human volunteers for three months, where optimized O-NLC-E and B-NLC-E were regularly applied on cheeks. Non-invasive procedures were used to assess the volunteer’s skin erythema, TEWL, sebum level, melanin, hydration, pH, elasticity, and pore sizes after specified intervals. The results demonstrated that applying O-NLC-E formulation to the skin of volunteers directed significant antiaging benefits. The study offers nanotechnology-based sustainability approach against skin ageing.
- 3 July 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (7) , 798
Open AccessEco-Friendly Sustainable Nanocarriers to Treat Oxidative Stresses and Skin Aging-Related Ailments, Valorization of a By-Product
The peel from Citrus-sinensis L. is a medicinally significant food waste, and its extract (O-Ext) could be significant against oxidative stresses and skin aging, However, the penetration barriers, instability in formulation, undefined toxicities, and enzymatic activities make the O-Ext difficult to formulate and commercialize. The goal of this study was to evaluate O-Ext against oxidative stress, prepare O-Ext-loaded nano-lipid carriers (O-NLCs), and load them into topical O/W-emulsion (O-NLC-E) to improve O-Ext permeation and its in vivo antiaging effects. TPC, TFC, DPPH activity, and mineral/metal contents of O-Ext were determined via atomic-absorption spectroscopy. For bioactive compounds profiling, GC-MS analysis was carried out. O-NLCs were prepared and tested for physicochemical attributes, while HaCaT and fibroblast cells were used to study permeation and cytotoxicity. The kinetic characteristics of ex vivo permeation through rat skin were established, following the Higuchi model. Following written consent, safety investigations were conducted on human volunteers for three months, where optimized O-NLC-E and B-NLC-E were regularly applied on cheeks. Non-invasive procedures were used to assess the volunteer’s skin erythema, TEWL, sebum level, melanin, hydration, pH, elasticity, and pore sizes after specified intervals. The results demonstrated that applying O-NLC-E formulation to the skin of volunteers directed significant antiaging benefits. The study offers nanotechnology-based sustainability approach against skin ageing.